AETNA SERIES FUND INC
DEFS14A, 1998-07-22
Previous: FIRST TRUST COMBINED SERIES 139, 24F-2NT, 1998-07-22
Next: SPARTAN STORES INC, 424B3, 1998-07-22






            
                                                 

                     INFORMATION REQUIRED IN PROXY STATEMENT
                            SCHEDULE 14A INFORMATION
              Proxy Statement Pursuant to Section 14(A) of the
              Securities Exchange Act of 1934 (Amendment No.__ )


Filed by the Registrant                    [x]
Filed by a Party other than the Registrant [ ]
Check the appropriate box:

[ ]   Preliminary Proxy Statement    [ ] Confidential, for Use of
                                         the Commission Only
                                         (as permitted by Rule 14a-6(e)(2))
[x]      Definitive Proxy Statement
[ ]      Definitive additional materials
[ ]      Soliciting material pursuant to Rule 14a-11(c) or Rule 14a-12

                             AETNA SERIES FUND, INC.
                         AETNA VARIABLE PORTFOLIOS, INC.
      (Name of Registrant as Specified in Its Charter/Declaration of Trust)

      (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of filing fee (Check the appropriate box):

[x]      No fee required.
[ ]      Fee  computed on table below per Exchange Act Rules 14a-6(i)(4)and
         0-11.

(1) Title of each class of securities to which transaction applies:

- --------------------------------------------------------------------------------
(2) Aggregate number of securities to which transaction applies:

- --------------------------------------------------------------------------------
(3)      Per unit  price  or other  underlying  value  of  transaction  computed
         pursuant to  Exchange  Act Rule 0-11 (Set forth the amount on which the
         filing fee is calculated and state how it was determined):

- --------------------------------------------------------------------------------
(4) Proposed maximum aggregate value of transaction:

- --------------------------------------------------------------------------------
(5) Total fee paid:

- --------------------------------------------------------------------------------
         Fee paid previously with preliminary materials:

- --------------------------------------------------------------------------------
[ ]      Check box if any part of the fee is offset as provided by Exchange  Act
         Rule  0-11(a)(2)  and identity the filing for which the  offsetting fee
         was paid  previously.  Identify  the  previous  filing by  registration
         statement number, or the form or schedule and the date of its filing.

(1)  Amount previously paid:

- --------------------------------------------------------------------------------
(2)  Form, Schedule or Registration Statement no.:

- --------------------------------------------------------------------------------
(3)  Filing Party:

- --------------------------------------------------------------------------------
(4)  Date Filed:



                                            

                             AETNA SERIES FUND, INC.
                          Aetna Value Opportunity Fund

                         AETNA VARIABLE PORTFOLIOS, INC.
                           Aetna Value Opportunity VP

Dear Fellow Shareholders and Contractholders:

         You are  cordially  invited by the Boards of  Directors of Aetna Series
Fund,  Inc. and Aetna Variable  Portfolios,  Inc. (each a "Fund"),  on behalf of
Aetna  Value  Opportunity  Fund and Aetna  Value  Opportunity  VP (each a "Value
Opportunity Series"),  respectively,  to attend a Special Meeting of each Fund's
Shareholders  (each a "Special  Meeting")  on  September 4, 1998 at 9:00 a.m. to
consider a recommendation which is important to you and your Fund.

   YOUR  PARTICIPATION  IN THIS PROCESS IS VERY IMPORTANT.  PLEASE READ THE 
ENCLOSED PROXY STATEMENT AND VOTE BY  COMPLETING,  SIGNING AND  RETURNING THE 
ENCLOSED  PROXY CARD. WE NEED YOUR VOTE TO OBTAIN THE QUORUM  NECESSARY
TO HOLD THE SPECIAL MEETINGS.

         The  proposal  to be voted on at each  Special  Meeting is  reviewed in
detail  in the  enclosed  Notice  and Proxy  Statement.  The  proposal  requests
approval of a subadvisory arrangement for each Value Opportunity Series.

     The  proposal  seeks your  approval of a new  subadvisory  agreement
pursuant to which  Bradley,  Foster & Sargent,  Inc.  ("Bradley")  will serve as
subadviser to your Value Opportunity Series, appointing Peter Canoni to serve as
portfolio  manager.  PLEASE  NOTE THAT THE NEW  SUBADVISORY  AGREEMENT  WILL NOT
RESULT IN ANY CHANGES IN ADVISORY FEES OR OTHER EXPENSES FOR EITHER OF THE VALUE
OPPORTUNITY  SERIES.  The new  subadvisory  agreement  is  intended  to maintain
continuity  of  management  for each  Value  Opportunity  Series in light of the
decision  of  its  portfolio  manager,  Peter  Canoni,  to  resign  from  Aeltus
Investment  Management,  Inc.  ("Aeltus"),  the Series' investment  adviser,  to
become a principal member of Bradley.  Bradley, a registered investment adviser,
currently has over $350 million under management.     

         The  Board of  Directors  of each  Fund has  carefully  considered  the
proposal to be voted on at this Special Meeting and unanimously  recommends your
approval of the new subadvisory agreement.

         If you have any  questions  related to the Special  Meeting  and/or the
Proxy Statement, please call us at 1-888-423-5887.

         Thank you for your participation in this process and your investment in
our Funds.

Sincerely,


J. Scott Fox
President

   July 22, 1998    



<PAGE>


                           NOTICE OF SPECIAL MEETINGS
                             OF THE SHAREHOLDERS OF


                             AETNA SERIES FUND, INC.
                          Aetna Value Opportunity Fund

                         AETNA VARIABLE PORTFOLIOS, INC.
                           Aetna Value Opportunity VP


         Special Meetings of the Shareholders (each a "Special Meeting") of each
of Aetna Series Fund, Inc. and Aetna Variable Portfolios,  Inc. (each a "Fund"),
on behalf of Aetna Value Opportunity Fund and Aetna Value Opportunity VP (each a
"Value Opportunity Series"), respectively, will be held on September 4, 1998, at
9:00  a.m.,  Eastern  time,  at  242  Trumbull  Street,  Hartford,   Connecticut
06103-1205 for the following purposes:

          1.       to approve or  disapprove a  Subadvisory  Agreement by and
 among Aeltus  Investment  Management, Inc., Bradley, Foster & Sargent, Inc. and
 the Fund, on behalf of its Value Opportunity Series; and

          2. to transact  such other  business as may  properly  come before the
Special Meeting and any adjournments thereof.

         Shareholders  of record at the close of business  on June 30,  1998
are entitled to notice of and to vote at the Special Meeting.

                                                              Amy R. Doberman
                                                              Secretary


   July 22, 1998    



<PAGE>




                             AETNA SERIES FUND, INC.
                          Aetna Value Opportunity Fund

                         AETNA VARIABLE PORTFOLIOS, INC.
                           Aetna Value Opportunity VP


                              JOINT PROXY STATEMENT
                                 JULY 22, 1998    


         This Proxy Statement is given to you to provide  information you should
review before  voting on the matter listed in the Notice of Special  Meetings on
the  previous  page for each of Aetna  Series  Fund,  Inc.  and  Aetna  Variable
Portfolios,  Inc. (each a "Fund"), on behalf of Aetna Value Opportunity Fund and
Aetna  Value  Opportunity  VP (each a "Series" or "Value  Opportunity  Series"),
respectively.  Your Fund's Board of Directors  (the  "Directors")  is soliciting
your vote for a  Special  Meeting  of  Shareholders  of the Fund  (the  "Special
Meeting") to be held at 242 Trumbull Street,  Hartford,  Connecticut 06103-1205,
on September 4, 1998, at 9:00 a.m., Eastern time, and, if the Special Meeting is
adjourned, at any adjournment of that Meeting.

     This Proxy  Statement  describes the matter that will be voted on at
the Special Meeting (the  "Proposal").  The solicitation of votes is made by the
mailing of this Proxy Statement and the accompanying proxy card or authorization
card on or about July 22, 1998. Aeltus Investment  Management,  Inc.  ("Aeltus")
and its affiliates may contact Fund shareholders  directly  commencing in August
1998 to discuss the Proposal. The expenses incurred in connection with preparing
this Proxy Statement and its enclosures and of all solicitations will be paid by
Aeltus.    

         A copy of Aetna Value  Opportunity  VP's  Annual  Report for the fiscal
year  ended  December  31,  1997,  was  mailed to its  shareholders  on or about
February 28, 1998. That Series' Semi-Annual Report for the period ended June 30,
1998 will be mailed to its  shareholders  on or about  September 4, 1998.  Aetna
Value Opportunity Fund's Semi-Annual Report for the period from February 2, 1998
(commencement   of  operations)  to  April  30,  1998  will  be  mailed  to  its
shareholders  on or about June 29,  1998.  Aetna Value  Opportunity  VP's Annual
Report and each Value Opportunity Series' most recent Semi-Annual Report will be
provided to the applicable Series' shareholders upon request, without charge. If
you did not receive an Annual Report or Semi-Annual  Report, as applicable,  for
your Value Opportunity  Series, you may request one by writing to Wayne Baltzer,
c/o Aeltus  Investment  Management,  Inc., ALT7 242 Trumbull  Street,  Hartford,
Connecticut, 06103-1205, or by calling 1-888-423-5887.

     Shareholders  of record on June 30,  1998 (the  "record  date")  are
entitled  to be present  and to vote at the  Special  Meeting  or any  adjourned
meeting.  As of the record date, Aetna Value Opportunity VP offered one class of
shares and Aetna  Value  Opportunity  Fund  offered two classes of shares to the
public:  Class A shares and Class I shares. Class A shares and Class I shares of
Aetna Value  Opportunity Fund have the same rights,  privileges and preferences,
except  with  respect  to:  (a) the  effect of sales  charges,  if any;  (b) the
different distribution and/or service fees borne by each class; (c) the expenses
allocable  exclusively to each class;  (d) voting rights on matters  exclusively
affecting a single class;  and (e) the exchange  privilege of each class.  As of
the record date, each Value  Opportunity  Series had the following shares issued
and outstanding:    

   
[S]                                             [C]
                                                Number of Shares
                                                Outstanding as of June 30, 1998
AETNA SERIES FUND, INC.
Aetna Value Opportunity Fund
     Class A                                    29,771.96
     Class I                                    488,108.97
AETNA VARIABLE PORTFOLIOS, INC.
Aetna Value Opportunity VP                      4,258,042.45
    
         As of the  record  date,  Aetna Life  Insurance  and  Annuity  Company*
("ALIAC") and its affiliates owned the following amount of shares of Aetna Value
Opportunity Fund:

   
[S]                               [C]                       [C]
                                                            Amount and
                                                            Nature of
                                 Beneficial Ownership**     Percent of Class
AETNA SERIES FUND, INC.
Aetna Value Opportunity Fund
     Class A                    10,000.00                      33.59%
     Class I                   480,942.03                      98.53%

[FN]
   *ALIAC's  principal  office is located at 151  Farmington  Avenue,  Hartford,
 Connecticut  06156-8962.  **ALIAC  and its  affiliates  have  sole  voting  and
 investment power with respect to the shares.

    
         Shares of Aetna  Value  Opportunity  VP are offered  only to  insurance
companies to fund benefits under their variable  annuity  contracts and variable
life insurance policies. Accordingly, as of the record date, all shares of Aetna
Value Opportunity VP were held by separate accounts of ALIAC and its subsidiary,
Aetna  Insurance  Company of America,  Inc. ( "Aetna  Insurance"),  on behalf of
their respective  separate accounts.  These shares were owned by ALIAC and Aetna
Insurance as  depositors  for their  respective  variable  annuity  contracts or
variable  life  insurance  policies  (each a  "Contract")  issued to  individual
contractholders  or to a group of which  the  individual  contractholders  are a
part.  Under  the  terms of the  Contracts,  contractholders  have the  right to
instruct  ALIAC and Aetna  Insurance  how to vote the  shares  related  to their
interests  through  their  Contracts.  This Proxy  Statement  is used to solicit
instructions  for voting  shares of Aetna  Value  Opportunity  VP.  All  persons
entitled to direct the voting of shares,  whether or not they are  shareholders,
will be described as voting for purposes of this Proxy Statement.

         The  shares  of Aetna  Value  Opportunity  VP held by ALIAC  and  Aetna
Insurance  are held on behalf of the  following  separate  accounts  which  hold
assets for the Contracts:

   
[S]                                           [C]                       [C]
Separate Account Name                   Number of Shares             Percentage

LIAC Separate Account B                  1,236,607.93                   29.04%
ALIAC Separate Account C                 1,945,002.54                   45.68%
ALIAC Separate Account D                   755,785.50                   17.75%
AICA Separate Account I                    320,646.48                    7.53%
    

         ALIAC  and  Aetna  Insurance  will  vote  the  shares  of  Aetna  Value
Opportunity VP held in their names as directed. The group contractholder of some
group  Contracts  has the  right to  direct  the vote for all  shares  under the
Contract,  for,  against or  abstaining,  in the same  proportions as shares for
which  instructions have been given under the same Contract.  If ALIAC and Aetna
Insurance do not receive  voting  instructions  for all of the shares held under
Contracts,  they will vote all the shares in all the listed  separate  accounts,
for, against or abstaining, in the same proportions as the shares for which they
have received instructions.

         To the best of each Fund's knowledge,  as of the record date, no person
owned  beneficially more than 5% of any class of its Value  Opportunity  Series,
except as stated  above.  As of the record date,  officers and Directors of each
Fund, both  individually  and as a group,  owned less than 1% of the outstanding
shares of any class of the applicable Fund's Value Opportunity Series.

         In the event that a quorum of  shareholders  is not  represented at the
Special Meeting, the Meeting may be adjourned until a quorum exists, or, even if
a quorum is represented,  the Meeting may be adjourned until sufficient votes to
approve the proposal are received. More than 50% of the total outstanding shares
of a Value  Opportunity  Series must be present at the Special Meeting to have a
quorum to conduct business. For purposes of determining the presence of a quorum
for  transacting  business  at  the  Special  Meeting,  abstentions  and  broker
"non-votes"  will be treated as shares  that are present but which have not been
voted.  Broker non-votes are proxies received by a Fund from brokers or nominees
when the broker or nominee has neither received instructions from the beneficial
owner or other persons entitled to vote nor has discretionary power to vote on a
particular  matter. The persons named as proxies may propose and vote for one or
more  adjournments  of the Special  Meeting in accordance  with  applicable law.
Adjourned  meetings  must be held  within  a  reasonable  time  after  the  date
originally  set for the  meeting  (but not more than 120 days  after the  record
date).  Solicitation  of votes may continue to be made without any obligation to
provide any additional  notice of the adjournment.  The persons named as proxies
will vote Value  Opportunity  Series shares in favor of such  adjournment  those
proxies  which they are entitled to vote in favor and will vote against any such
adjournment those proxies to be voted against the Proposal.

         The Proposal requires the vote of a "majority of the outstanding voting
securities" of a Value Opportunity Series. A "majority of the outstanding voting
securities" of a Value  Opportunity  Series means the lesser of: (i) 67% of that
Series' shares present at the Special  Meeting,  if the holders of more than 50%
of the shares of that Series then outstanding are present in person or by proxy;
or (ii) more  than 50% of the  outstanding  voting  securities  of that  Series.
Shareholders  of Aetna  Value  Opportunity  Fund  will  vote as a  single  class
regardless of whether they are Class A or Class I  shareholders.  If the vote is
determined  on the basis of the  affirmative  vote of 67% of the Series'  shares
present at the Special Meeting, as described in clause (i) of the first sentence
of this paragraph, abstentions and broker non-votes will not constitute "yes" or
"no" votes for the Proposal and will be disregarded  in  determining  the voting
securities  present. If the Proposal is determined on the basis of obtaining the
affirmative  vote of more than 50% of all the outstanding  voting  securities of
the Series,  as described in clause (ii) above,  broker  non-votes will have the
effect of a "no" vote on the Proposal.

         The number of shares that you may vote is the total of the number shown
on the proxy card or authorization  card, as the case may be,  accompanying this
Proxy  Statement.  If you own  shares of Aetna  Value  Opportunity  VP through a
Contract,  the number of shares  which you are  entitled  to vote is  calculated
according to the formula  described in the materials  relating to your Contract.
Shareholders  are  entitled to one vote for each full share and a  proportionate
vote for each fractional  share held.  Votes may be revoked by written notice to
Aeltus prior to the Special  Meeting or by  attending  the Meeting in person and
indicating that you want to vote your shares.

         Shares of Aetna Value Opportunity Fund held by ALIAC and its affiliates
will be voted in the same proportion as shares held by non-ALIAC shareholders of
that Series.

         The  appointed  proxies  will  vote in their  discretion  on any  other
business as may properly come before the Special Meeting or any  adjournments or
postponements  thereof.  Additional matters would only include matters that were
not anticipated as of the date of this Proxy Statement.

                             MATTER TO BE ACTED UPON

                                    PROPOSAL 1
                        APPROVAL OF SUBADVISORY AGREEMENT
                        FOR EACH VALUE OPPORTUNITY SERIES

         The  Directors  of  each  Fund,  including  the  Directors  who are not
"interested  persons" of the Fund (the "Independent  Directors"),  as defined by
the  Investment  Company  Act  of  1940,  as  amended  (the  "1940  Act"),  have
unanimously  approved,  and  recommend  that  the  shareholders  of  each  Value
Opportunity  Series  approve,  a  subadvisory  agreement  for  the  Series  (the
"Subadvisory  Agreement"),  among the  applicable  Fund,  on behalf of its Value
Opportunity Series, Aeltus, and Bradley, Foster & Sargent, Inc. ("Bradley").

         Shareholders  of each  Value  Opportunity  Series  are  being  asked to
approve a separate Subadvisory Agreement for their Series.

         The Subadvisory  Agreements on behalf of each Value Opportunity  Series
are identical in all material  respects.  A copy of the form of the  Subadvisory
Agreement is included with this Proxy Statement as Exhibit A.

WHAT ARE THE SIGNIFICANT PROVISIONS OF THE EXISTING INVESTMENT ADVISORY 
AGREEMENTS?

     Aeltus acts as investment  adviser to each Value Opportunity  Series
pursuant to investment  advisory agreements entered into between Aeltus and each
Fund, on behalf of its Value Opportunity Series (each an "Advisory  Agreement").
The Advisory  Agreement between Aeltus and Aetna Variable  Portfolios,  Inc., on
behalf of its Value Opportunity  Series, was approved by the Fund's Directors on
December  10,  1997,  became  effective  May 1, 1998 and  replaces  the advisory
agreement with ALIAC, the Fund's former investment adviser,  which agreement was
approved by the Series' sole  shareholder  on September  13, 1996.  The Advisory
Agreement  between  Aeltus and Aetna Series Fund,  Inc.,  on behalf of its Value
Opportunity  Series,  was also approved by the Fund's  Directors on December 10,
1997,  became  effective  February 2, 1998 and was  approved by the Series' sole
shareholder  effective  February 2, 1998.  Each Advisory  Agreement gives Aeltus
broad latitude in selecting securities for each Value Opportunity Series subject
to the Directors' oversight.  Under the Advisory Agreement,  Aeltus may delegate
to a  subadviser  some or all of its  responsibilities  in  managing  each Value
Opportunity  Series' investment  portfolio,  subject to Aeltus'  oversight.  The
Advisory  Agreement also provides that Aeltus is responsible  for all of its own
costs, including costs of Aeltus' personnel required to carry out its investment
advisory duties.    

         Each Advisory  Agreement  allows Aeltus to place trades through brokers
of its  choosing  and to take into  consideration  the  quality of the  brokers'
services and execution,  as well as services such as research,  or paying Series
expenses,  in setting the amount of commissions paid to a broker. Aeltus may pay
higher commission rates than the lowest available when it is reasonable to do so
in light of the value of the brokerage and research services received  generally
or  in  connection  with  a  particular  transaction.  Aeltus  only  uses  these
commissions for services and expenses to the extent authorized by applicable law
and the rules and  regulations of the Securities  and Exchange  Commission  (the
"SEC"). It is Aeltus' policy to obtain the best quality of execution  available,
giving attention to net price (including commission where applicable), execution
capability  (including the adequacy of a firm's capital position),  research and
other  services  related to  execution;  the  relative  priority  given to these
factors will depend on all of the circumstances regarding a specific trade.

         Aeltus receives brokerage and research services from brokerage firms in
return for the execution by such brokerage  firms of trades on behalf of a Fund.
These  brokerage  and research  services  may  include,  but are not limited to,
quantitative  and  qualitative   research  information  and  purchase  and  sale
recommendations  regarding  securities  and  industries,  analyses  and  reports
covering a broad range of economic factors and trends, statistical data relating
to the strategy and performance of its series,  including the Value  Opportunity
Series,  and other  investment  companies,  services related to the execution of
trades in a Series' securities and advice as to the valuation of securities, the
providing of equipment used to communicate  research information and specialized
consultations  with Series'  personnel with respect to computerized  systems and
data furnished to the Series as a component of other research services.

         Research  services  furnished  by brokers  through  whom a Fund effects
securities  transactions may be used by Aeltus in servicing all of its accounts;
not all such services will be used by Aeltus to benefit the Fund.

     Each Advisory  Agreement  provides that it will be effective through
December 31, 1999 and thereafter from year to year if approved by the Directors,
including a majority of the Independent Directors.  Each Advisory Agreement will
terminate  automatically if there is an assignment of the agreement,  as defined
in the 1940 Act. It can be  terminated  by the  Directors,  shareholders  of the
Value Opportunity Series, or Aeltus on 60 days' notice.    

WHO IS AELTUS?

         Aeltus is a  Connecticut  corporation  organized in 1972 under the name
Aetna Capital  Management,  Inc. It currently  has its principal  offices at 242
Trumbull  Street,  Hartford,   Connecticut.  Aeltus  is  a  part  of  the  Aetna
organization,  and  is an  affiliate  of  ALIAC  and  an  indirect  wholly-owned
subsidiary  of Aetna Inc.,  a financial  services  company with stock listed for
trading  on the New York Stock  Exchange.  John Y. Kim  currently  serves as the
President,  Chief  Executive  Officer  and Chief  Investment  Officer of Aeltus.
Aeltus is  registered  with the SEC as an  investment  adviser.  In  addition to
providing   investment   advisory   services,   Aeltus  serves  as  each  Fund's
administrator  and provides  certain  administrative  and  shareholder  services
necessary for Fund  operations and is responsible  for the  supervision of other
service  providers.  The  principal  underwriter  of Aetna Series Fund,  Inc. is
Aeltus Capital, Inc., 242 Trumbull Street,  Hartford,  Connecticut 06103-1205, a
wholly-owned  subsidiary  of Aeltus and an indirect  wholly-owned  subsidiary of
Aetna Inc. ALIAC serves as principal  underwriter to Aetna Variable  Portfolios,
Inc.  These  entities will  continue to provide  services to the Funds after the
approval of the proposed subadvisory arrangements.

WHAT FEES OR CHARGES ARE PAID BY EACH VALUE OPPORTUNITY SERIES?

         During  1997,  ALIAC,  an  affiliate  of Aeltus,  served as  investment
adviser,  administrator and principal underwriter to the Aetna Value Opportunity
VP. ALIAC  received  fees for serving as the  investment  adviser to Aetna Value
Opportunity VP and for providing  administrative services to it. The table below
describes  the fees that ALIAC  received  from Aetna  Value  Opportunity  VP for
providing these services for the fiscal year ended December 31, 1997.



  
  
[S]                [C]            [C]                [C]
                   MANAGEMENT     ADMINISTRATIVE     DISTRIBUTION
SERIES*            FEES           SERVICES FEES      FEES
Aetna Value 
Opportunity VP     $38,520        $9,630              $0
[FN]
* Fee  information  is not available  for Aetna Value  Opportunity  Fund,  which
commenced operations on February 2, 1998.

         

     Below are schedules that list the annual  advisory fee rate for each
Value  Opportunity  Series.  As of June 30, 1998,  the net assets of Aetna Value
Opportunity Fund and Aetna Value Opportunity VP were $5,806,271 and $56,594,953,
respectively.    

                            SERIES MANAGEMENT FEE SCHEDULES
(expressed as a percentage of each Value Opportunity Series' average daily
 net assets)

         Aetna Value Opportunity Fund:

                  0.70% on the first $250 million 0.65% on the next $250 million
                  0.625% on next $250 million  0.60% on next $1.25 billion 0.55%
                  over $2 billion

         Aetna Value Opportunity VP

                  0.60%

WHY IS AELTUS PROPOSING A SUBADVISORY ARRANGEMENT?

     Peter  B.  Canoni,  a  Managing  Director  of  Aeltus,  has been the
portfolio manager for the Value Opportunity Series since each Series' inception.
Mr. Canoni recently  decided to resign from Aeltus  effective  August 1, 1998 to
become a  principal  member  of  Bradley.  In order to  maintain  continuity  of
management for each Value Opportunity Series, Aeltus proposes that each Fund, on
behalf of its Value Opportunity Series, enter into a Subadvisory  Agreement with
Bradley. Following Mr. Canoni's departure, one or more Aeltus portfolio managers
will  manage  each Value  Opportunity  Series on an interim  basis  pending  the
outcome of the Proposal at the Special Meeting. If the subadvisory  relationship
is  approved  for  the  Value  Opportunity  Series,  Mr.  Canoni,  as a  Bradley
principal,  will  serve  as  portfolio  manager.  Mr.  Canoni  has 26  years  of
investment  experience  and  in-depth  knowledge of the equity  markets.  Aeltus
expects to retain  Bradley as a Subadviser  only so long as Mr. Canoni serves as
portfolio manager of the Value Opportunity  Series.  Each Subadvisory  Agreement
can be terminated by Aeltus,  Bradley or the  applicable  Fund, on behalf of its
Value  Opportunity  Series,  on 60  days'  notice.  In  this  regard,  Bradley's
relationship  with  the Fund may be  terminated  if,  for  example,  the  Series
performance results are unsatisfactory,  Mr. Canoni is no longer associated with
Bradley,  or he elects not to continue assuming  day-to-day  responsibility  for
management of the Series.    

         Under  the  Subadvisory  Agreements,  Aeltus  would  bear the  ultimate
responsibility  for  overseeing  the  investment  advice  provided to each Value
Opportunity Series. It would monitor Bradley's activities to ensure that Bradley
is following  regulatory  requirements,  and Board  policies,  restrictions  and
guidelines  in managing  each Value  Opportunity  Series'  assets.  Aeltus would
determine that Bradley had established and at all times  maintained  appropriate
policies and procedures  including,  but not limited to, a code of ethics, which
are designed to ensure that the management of each Value  Opportunity  Series is
implemented  in  compliance  with the 1940 Act, the  Investment  Advisers Act of
1940, as amended, and the rules thereunder.  Aeltus believes that its experience
in managing  assets for mutual funds  should  enable it to  effectively  monitor
Bradley's  activities  to  the  advantage  of  each  Value  Opportunity  Series'
shareholders.

WHO IS BRADLEY?

         Bradley,  a Connecticut  corporation  organized in 1993,  maintains its
primary  office at City  Place II - 185  Asylum  Street,  Hartford,  Connecticut
06103.  It is  registered  with the SEC as an  investment  adviser  and  manages
private  client assets as well as 401(k),  profit  sharing and other  retirement
plan  assets.  Bradley has not  previously  served as an  investment  adviser or
subadviser  to a mutual fund. As of June 1, 1998,  Bradley  managed in excess of
$350 million of assets.

     The principal  occupations and positions of Bradley's  principal  
executive  officer and each principal are as follows:    

   
       [S]                                         [C]
NAME AND ADDRESS*                       PRINCIPAL OCCUPATION
Robert H. Bradley **    Principal and President, Bradley, Foster & Sargent, Inc.
Timothy H. Foster              Principal, Bradley, Foster & Sargent, Inc.
Joseph D. Sargent              Principal, Bradley, Foster & Sargent, Inc.
Jeffrey G. Marsted             Principal, Bradley, Foster & Sargent, Inc.
J. Edward Roney, Jr.           Principal, Bradley, Foster & Sargent, Inc.
[FN]
*  The principal business address of each person listed above, other than Mr.
Roney, is City Place II - 185 Asylum Street, Hartford, Connecticut 06103.  The 
principal business address of Mr. Roney is 79 Milk Street, Boston, Massachusetts
02109.
**  Principal executive officer.


    



         No  officer or  Director  of either  Fund is an  officer,  employee  or
director of Bradley.  No officer or Director of either Fund owns any  securities
of, or has any other material direct or indirect  interest in, Bradley or any of
its  affiliates.  No  Director  of either  Fund has had any  direct or  indirect
material  interest in any material  transaction since January 1, 1997, or in any
material proposed transactions,  to which Bradley or any subsidiary was or is to
be a party.  There is no arrangement  or  understanding  in connection  with the
Subadvisory Agreements with respect to the composition of the Board of Directors
of either Fund or of Bradley, or with respect to the selection or appointment of
any person to any office of any such  company.  As  described  more fully above,
however,  it is  contemplated  in  connection  with the approval of the proposed
Subadvisory  Agreements  that  Bradley  will  appoint  Peter Canoni as portfolio
manager of each Value Opportunity Series.

         Bradley   utilizes  an  Investment   Committee  to  review  and  select
securities  for inclusion in its "Guidance  List." All  securities  purchased on
behalf  of  a  client's  portfolio,   including  the  portfolios  of  the  Value
Opportunity  Series, must be on the Guidance List. The decision to add or delete
a security from the List is made by the Investment Committee.  Each principal of
the firm is a member of the Investment Committee. When Mr. Canoni joins Bradley,
he will become a  principal  of the firm and a voting  member of the  Investment
Committee.  Decisions  by Mr.  Canoni as to the timing of  purchases or sales of
securities would not require the approval of the Investment Committee.  Instead,
only the addition of new securities to the Guidance List need be approved by the
Investment  Committee in advance.  Mr. Canoni will inform the Board of Directors
of each Fund in the event that his management of the investment portfolio of the
Value  Opportunity  Series has been constrained by the existence of the Guidance
List.

WHAT ARE THE MATERIAL TERMS OF THE PROPOSED SUBADVISORY AGREEMENTS WITH BRADLEY?

         The  Subadvisory  Agreements  give Bradley broad  latitude in selecting
securities  for each Value  Opportunity  Series  consistent  with the investment
objectives  and  policies  of the  Series,  subject  to Aeltus'  oversight.  The
Agreements  contemplate  that  Bradley will be  responsible  only for making and
communicating investment decisions. Aeltus will remain responsible for all other
aspects of managing and administering the Value  Opportunity  Series,  including
trade  execution.  Aeltus  will cause  Bradley  to be  provided  with  continued
communication with its sell-side  brokerage  relationships.  Aeltus will provide
Bradley with current portfolio  information,  including cash positions.  Bradley
will provide all other  necessary  support to the investment  decision  process.
Bradley will institute internal  compliance  policies and procedures designed to
monitor  potential  conflicts of interest  that may arise from trades  placed on
behalf of the Value  Opportunity  Series and on behalf of other Bradley clients.
The Subadvisory Agreements provide that Bradley is not precluded from serving as
adviser  or  subadviser  to any other  registered  investment  company or series
thereof;  provided however, that no such investment company or series shall have
investment  objectives,  strategies  and  restrictions  that  are  substantially
similar  to  those  employed  by the  Value  Opportunity  Series  unless  Aeltus
expressly consents.

     The Subadvisory  Agreements,  if approved, will be effective October 1, 
1998 or, if the Special  Meeting is  adjourned,  on the first day of the next
month  following  the date on which the  shareholders  approve  the  Subadvisory
Agreements.  They will continue in effect until December 31, 1999 and thereafter
from year to year if approved by the Directors of the applicable Fund, including
a majority of the Independent  Directors. A Subadvisory Agreement will terminate
automatically if the corresponding  Investment Advisory Agreement  terminates or
if there is a change in control of Bradley.  Each can be  terminated  by Aeltus,
Bradley or the applicable Fund, on behalf of its Value Opportunity Series, on 60
days'  notice.  If the  Subadvisory  Agreement  terminates,  Aeltus,  the  Value
Opportunity   Series'  investment  adviser,   would  automatically   assume  all
management  functions  for the Series.  Bradley can be held liable to Aeltus and
the Funds for negligence,  bad faith,  willful malfeasance or reckless disregard
of its obligations or duties under the Subadvisory Agreements.    

     WHAT WILL AELTUS PAY UNDER THE SUBADVISORY AGREEMENTS ON BEHALF OF EACH 
SERIES?    

         The Subadvisory  Agreement for each Value  Opportunity  Series provides
that, for the duration of the Agreement,  Bradley's subadvisory fee will be paid
monthly at an annual  rate of 0.15% of the Series'  average  daily net assets on
the first $250  million of assets,  and 0.10% of the Series'  average  daily net
assets on assets above $250 million.

     Aeltus  believes this proposed  compensation  is fair and reasonable
for the services being provided by Bradley. The fees are not charged back to, or
paid by, a Value  Opportunity  Series;  they are paid by  Aeltus  out of its own
resources,  including  fees and charges it receives from or in  connection  with
each Fund. If the subadvisory agreements are approved,  Aeltus intends to retain
Bradley to provide  certain  shareholder  communication  services and  marketing
assistance  through  December 31, 1999.  The fee for these  services has not yet
been determined but is expected to be approximately $13,000 per month.    

WHAT IS EACH BOARD OF DIRECTORS' RECOMMENDATION?

         The Board of Directors of each Fund unanimously  recommends  voting FOR
approval of the Subadvisory Agreement on behalf of its Value Opportunity Series.

WHAT FACTORS DID EACH BOARD OF DIRECTORS CONSIDER IN REACHING ITS
RECOMMENDATION?

     The  Directors  of each Fund  considered  the  proposed  Subadvisory
Agreement  applicable to its Value Opportunity  Series at a meeting held on June
24, 1998. The Contract Review  Committee of each Board of Directors,  consisting
solely of the Independent  Directors,  considered the Subadvisory Agreement at a
meeting held on June 23, 1998.  In  preparation  for the Contract  Committee and
Board  meetings,  counsel  for  the  Independent  Directors  requested,  and the
Directors were provided, certain relevant information, including: Bradley's Form
ADV, as well as a detailed background of the firm and its principals,  Bradley's
financial  statements,  Bradley's  performance  record achieved on behalf of its
clients and assets under  management,  Bradley's Code of  Professional  Conduct,
information  with respect to Bradley's  compliance  record,  Bradley's record of
client  service and  communication,  Mr.  Canoni's  performance as the portfolio
manager of the Value Opportunity  Series,  and a copy of the form of subadvisory
agreement.    

     The  Directors   acknowledged   that  approval  of  the  Subadvisory
Agreement  would mean that the  shareholders  would  receive the benefits of the
talents of Aeltus and  Bradley,  including  Mr.  Canoni,  working  for the Value
Opportunity Series at no additional cost to shareholders.     

     In  recommending  the approval of the  Subadvisory  Agreement to the
shareholders  of its Value  Opportunity  Series,  each Fund's Board of Directors
considered  such  factors as it deemed  reasonably  necessary  and  appropriate,
including:  (1) the fact that the Subadvisory  Agreement would permit that Value
Opportunity  Series  to  continue  to  receive  the  services  of Mr.  Canoni as
portfolio manager;  (2) the nature and quality of the services to be provided to
the Value Opportunity  Series;  (3) the compensation to be paid to Bradley;  (4)
Bradley's  financial  soundness;  (5) Mr.  Canoni's  experience  as a  portfolio
manager generally and in connection with his management of the Value Opportunity
Series;  (6) the performance of the Value Opportunity Series during Mr. Canoni's
tenure as a portfolio manager relative to the performance of comparably  managed
mutual funds; (7) Bradley's personnel,  resources,  investment methodology,  and
investment  management  experience;  (8)  the  total  fees  paid  by  the  Value
Opportunity  Series;  and (9) the fact that  none of the  expenses  incurred  in
connection with this proxy  solicitation and the related  transactions  would be
borne by the Value Opportunity  Series.  Each Board of Directors also noted that
the  advisory  fees paid by each Fund to Aeltus  would  remain the same and that
Aeltus would pay all fees to Bradley under the Subadvisory  Agreement.  Although
the Board of Directors of each Fund  considered  the above  factors in approving
the Subadvisory  Agreement,  each Board attached particular  significance to the
fact that Mr.  Canoni will serve as portfolio  manager of the Value  Opportunity
Series. After considering the above factors, each Board of Directors,  including
the Independent  Directors,  concluded that the Subadvisory Agreement was in the
best interest of shareholders of the Value Opportunity Series.     

   WHAT HAPPENS IF THE SUBADVISORY AGREEMENTS ARE NOT APPROVED?    

     If  the  Subadvisory  Agreements  are not  approved  for both  Value
Opportunity  Series,  Aeltus would continue as investment adviser to both Series
and would appoint a permanent  portfolio  manager for them.  Aeltus reserves the
right to adjourn the meeting if it reasonably  believes that the shareholders of
either Value Opportunity Series will not vote to approve the proposal.    

OTHER BUSINESS

         The  management of each Fund knows of no other business to be presented
at the Special Meeting other than the matter set forth in this Proxy  Statement.
If any other  business  properly comes before the Special  Meeting,  the proxies
will exercise their best judgment in deciding how to vote on such matters.

SHAREHOLDER PROPOSALS
         The Articles of Incorporation and the By-Laws of each Fund provide that
the Fund need not hold annual  shareholder  meetings,  except as required by the
1940 Act. Therefore,  it is probable that no annual meeting of shareholders will
be held in 1998 or in  subsequent  years until so  required.  For those years in
which annual  shareholder  meetings are held,  proposals which shareholders of a
Fund intend to present for inclusion in the proxy  materials with respect to the
annual meeting of shareholders  must be received by the Fund within a reasonable
period of time before the solicitation is made.

     Please  complete the enclosed proxy card or  authorization  card, as
applicable,  and return it promptly in the enclosed self-addressed  postage-paid
envelope.  You may revoke your proxy at any time prior to the Special Meeting by
written notice to Aeltus or by submitting a proxy card or an authorization card,
as the case may be, bearing a later date.    

                                                              Amy R. Doberman
                                                              Secretary




<PAGE>



                                                                      Exhibit A

                              SUBADVISORY AGREEMENT

THIS  AGREEMENT is made by AELTUS  INVESTMENT  MANAGEMENT,  INC., a  Connecticut
corporation  (the  "Adviser"),  [NAME OF  FUND],  a  Maryland  Corporation  (the
"Fund"),  on behalf of its [NAME OF VALUE OPPORTUNITY  SERIES] (the "Portfolio")
and  Bradley,   Foster  &  Sargent,   Inc.,  a  Connecticut   corporation   (the
"Subadviser"), as of the date set forth below.

                               W I T N E S S E T H

WHEREAS, the Fund is registered with the Securities and Exchange Commission (the
"Commission")  as  an  open-end,  diversified,   management  investment  company
consisting of multiple investment  portfolios,  under the Investment Company Act
of 1940, as amended (the "1940 Act"); and

WHEREAS,  pursuant to authority granted by the Fund's Articles of Incorporation,
the Fund has established the Portfolio as a separate investment portfolio; and

WHEREAS,  both the Adviser and the Subadviser are registered with the Commission
as investment  advisers  under the  Investment  Advisers Act of 1940, as amended
(the  "Advisers  Act") and both are in the  business  of  acting  as  investment
advisers; and

WHEREAS,  the Adviser has entered into an Investment Advisory Agreement with the
Fund, on behalf of the Portfolio (the "Investment  Advisory  Agreement"),  which
appoints the Adviser as the investment adviser for the Portfolio; and

WHEREAS,  Article IV of the Investment Advisory Agreement authorizes the Adviser
to delegate all or a portion of its  obligations  under the Investment  Advisory
Agreement to a subadviser;

NOW THEREFORE, the parties agree as follows:


I.       APPOINTMENT AND OBLIGATIONS OF THE ADVISER

Subject to the terms and conditions of this Agreement, the Adviser and the Fund,
on behalf of the  Portfolio,  hereby appoint the Subadviser to manage the assets
of the Portfolio as set forth below in Section II, under the  supervision of the
Adviser  and  subject to the  approval  and  direction  of the  Fund's  Board of
Directors (the  "Board").  The Subadviser  hereby accepts such  appointment  and
agrees that it shall, for all purposes herein,  undertake such obligations as an
independent  contractor  and not as an  agent  of the  Adviser.  The  Subadviser
agrees,  that except as required to carry out its duties under this Agreement or
as otherwise expressly  authorized,  it has no authority to act for or represent
the Portfolio,  the Fund or the Adviser in any way. The  Subadviser  agrees that
the  Adviser  shall have the right at all times to inspect  the  offices and the
records of the Subadviser  that relate to the  Subadviser's  performance of this
Agreement.


II.      DUTIES OF THE SUBADVISER AND THE ADVISER

         A.       Duties of the Subadviser

         The Subadviser shall regularly  provide  investment advice with respect
         to the assets held by the  Portfolio and shall  continuously  supervise
         the investment and reinvestment of cash,  securities and instruments or
         other property comprising the assets of the Portfolio.  In carrying out
         these duties, the Subadviser shall:

                  1.       select  the  securities  to  be  purchased,  sold  or
                           exchanged by the  Portfolio or otherwise  represented
                           in the Portfolio's investment portfolio,  communicate
                           trade orders to the Adviser for all such  securities,
                           and regularly  report  thereon to the Adviser and, at
                           the request of the Adviser, to the Board;

                  2.       formulate and implement  continuing  programs for the
                           purchase and sale of securities and regularly  report
                           thereon to the  Adviser  and,  at the  request of the
                           Adviser or the Portfolio, to the Board; and

                  3.       establish  and  maintain   appropriate  policies  and
                           procedures  including,  but not limited to, a code of
                           ethics,   which  are  designed  to  ensure  that  the
                           management  of  the  Portfolio  is   implemented   in
                           compliance  with the 1940 Act, the Advisers  Act, and
                           the rules thereunder.


                   B.      Duties of the Adviser

         The Adviser shall retain responsibility for oversight of all activities
         of the  Subadviser  and for  monitoring its activities on behalf of the
         Portfolio. In carrying out its obligations under this Agreement and the
         Investment Advisory Agreement, the Adviser shall:

         1.       monitor  the  investment  program  maintained  by the
                  Subadviser  for the  Portfolio  and the  Subadviser's
                  compliance  program  to ensure  that the  Portfolio's
                  assets   are   invested   in   compliance   with  the
                  Subadvisory Agreement and the Portfolio's  investment
                  objectives  and  policies as adopted by the Board and
                  described in the most current effective  amendment of
                  the  registration  statement  for the  Portfolio,  as
                  filed with the Commission under the Securities Act of
                  1933,  as amended (the "1933 Act"),  and the 1940 Act
                  ("Registration Statement");

          2.       place all trade orders communicated by the Subadviser
                   with brokers or dealers selected by the Adviser.  The
                   Adviser shall use its best efforts to seek to execute 
                   portfolio  transactions at prices  that are  advantageous to
                   the  Portfolio  giving  consideration  to the services and
                   research  provided and at commission  rates that are
                   reasonable in relation to the benefits received;

          3.       review all  reports  prepared  by the  Subadviser  to
                   assure that they are in  compliance  with  applicable
                   requirements  and meet the  provisions  of applicable
                   laws and regulations;

          4.       file all periodic reports required to be filed by the
                   Portfolio with the applicable regulatory authorities;

          5.       review  and  deliver  to  the  Board  all  financial,
                   performance   and  other  reports   prepared  by  the
                   Subadviser  under the provisions of this Agreement or
                   as requested by the Board;

          6.       maintain  contact  with and enter  into  arrangements
                   with the custodian, transfer agent, auditors, outside
                   counsel,  and other third parties providing  services
                   to the Portfolio;

          7.       give    instructions   to   the   custodian    and/or
                   sub-custodian of the Portfolio, concerning deliveries
                   of  securities,  transfers of currencies and payments
                   of cash for the  Portfolio,  as required to carry out
                   the   investment   activities  of  the  Portfolio  as
                   contemplated by this Agreement;

          8.       provide such administrative and other services,  such
                   as preparation of financial  data,  determination  of
                   the Portfolio's  net asset value,  and preparation of
                   financial and performance reports; and

          9.       oversee  all  matters  relating to (i) the offer and sale of 
                   shares of the Portfolio, including promotions,  marketing
                   materials, preparation of  prospectuses,  filings with the  
                   Commission  and state  securities regulators,  and 
                   negotiations  with  broker-dealers;  (ii) shareholder
                   services,  including,  confirmations,  correspondence and
                   reporting to shareholders;  (iii) all corporate matters on
                   behalf of the Portfolio, including   monitoring   the  
                   corporate   records  of  the  Portfolio, maintaining  contact
                   with the Board,  preparing  for,  organizing  and attending
                   meetings of the Board and the Portfolio's shareholders; (iv)
                   preparation  of proxies when  required;  and (v) any other
                   matters not expressly delegated to the Subadviser by this 
                   Agreement.

          III.    REPRESENTATIONS AND WARRANTIES

         A.       Representations and Warranties of the Subadviser

         The  Subadviser  hereby  represents  and  warrants  to the  Adviser  as
follows:

                  1.       Due Incorporation and Organization. The Subadviser is
                           duly organized and is in good standing under the laws
                           of the State of Connecticut  and is fully  authorized
                           to enter into this Agreement and carry out its duties
                           and obligations hereunder.

                  2.       Registration.  The  Subadviser  is  registered  as an
                           investment  adviser  with the  Commission  under  the
                           Advisers  Act. The  Subadviser  shall  maintain  such
                           registration  in effect at all times  during the term
                           of this Agreement.

                  3.       Regulatory  Orders.  The Subadviser is not subject to
                           any stop orders,  injunctions  or other orders of any
                           regulatory  authority  affecting its ability to carry
                           out the terms of this Agreement.  The Subadviser will
                           notify the Adviser and the Portfolio  immediately  if
                           any such  order is  issued  or if any  proceeding  is
                           commenced that could result in such an order.

                  4.       Compliance.  The Subadviser  has in place  compliance
                           systems   and   procedures   designed   to  meet  the
                           requirements of the Advisers Act and the 1940 Act and
                           it shall at all times assure that its  activities  in
                           connection  with managing the Portfolio  follow these
                           procedures.

                  5.       Authority. The Subadviser is authorized to enter into
                           this Agreement and carry out the terms hereunder.

                  6.       Best  Efforts.  The  Subadviser  at all  times  shall
                           provide its best judgment and effort to the Portfolio
                           in carrying out its obligations hereunder.

         B.       Representations and Warranties of the Adviser

         The  Adviser  hereby  represents  and  warrants  to the  Subadviser  as
follows:

                  1.  Due Incorporation  and  Organization.  The Adviser is duly
                      organized  and is in good  standing  under the laws of the
                      State of Connecticut and is fully authorized to enter into
                      this  Agreement  and carry out its duties and  obligations
                      hereunder.

                  2.  Registration.  The Adviser is  registered as an investment
                      adviser with the  Commission  under the Advisers  Act. The
                      Adviser  shall  maintain such  registration  or license in
                      effect at all times during the term of this Agreement.

                  3.  Regulatory  Orders. The Adviser is not subject to any stop
                      orders,  injunctions  or other  orders  of any  regulatory
                      authority  affecting its ability to carry out the terms of
                      this Agreement. The Adviser will notify the Subadviser and
                      the Portfolio  immediately  if any such order is issued or
                      if any  proceeding is commenced  that could result in such
                      an order.

                  4.  Authority.  The Adviser is  authorized  to enter into this
                      Agreement and carry out the terms hereunder.

                  5.  Best  Efforts.  The Adviser at all times shall provide its
                      best  judgment and effort to the Portfolio in carrying out
                      its obligations hereunder.

         C.       Representations and Warranties of the Fund

     The Fund hereby represents and warrants to the Adviser as follows:    

                           1. Due Incorporation  and Organization.  The Fund has
                  been duly  incorporated as a Corporation under the laws of the
                  State of  Maryland  and it is  authorized  to enter  into this
                  Agreement and carry out its obligations hereunder.

                     
                  2.  Registration.  The  Fund is  registered  as an  investment
                  company with the  Commission  under the 1940 Act and shares of
                  the Fund are registered or qualified for offer and sale to the
                  public under the 1933 Act and all applicable  state securities
                  laws. Such  registrations  or  qualifications  will be kept in
                  effect during the term of this Agreement.    


IV.      CONTROL BY THE BOARD OF DIRECTORS

Any investment program undertaken by the Subadviser  pursuant to this Agreement,
as well as any other activities undertaken by the Subadviser at the direction of
the  Adviser  on behalf of the  Portfolio,  shall at all times be subject to any
directives of the Board.


V.       COMPLIANCE WITH APPLICABLE REQUIREMENTS

In carrying out its obligations  under this Agreement,  the Subadviser  shall at
all times conform to:

1. all  applicable  provisions  of the 1940 Act,  the  Advisers  Act and any
   rules and  regulations adopted thereunder;

2. all  policies  and  procedures  of the  Portfolio as adopted by the Board and
   as described in the Registration Statement;

3. the provisions of the Articles of Incorporation of the Fund, as amended from
   time to time;

4. the provisions of the Bylaws of the Fund, as amended from time to time; and

5. any other applicable provisions of state or federal law.


VI.      COMPENSATION

         The Adviser  shall pay the  Subadviser,  as  compensation  for services
         rendered  hereunder,  from its own  assets,  an annual fee based on the
         average daily net assets in the  Portfolio,  according to the following
         schedule:
    
     [S]                        [C]
     Net Assets in Portfolio   Annual Fee

     $0 - $250 MM              0.15% of the Portfolio's average daily net assets
     $250 MM                   0.10% of the Portfolio's average daily net assets
    
         The fee shall be  payable  monthly.  Except as  hereinafter  set forth,
         compensation under this Agreement shall be calculated and accrued daily
         at the rate of 1/365 of the annual fee  applied to the daily net assets
         of the Portfolio. If this Agreement becomes effective subsequent to the
         first day of a month or shall terminate before the last day of a month,
         compensation  for that part of the month  this  Agreement  is in effect
         shall be prorated in a manner  consistent  with the  calculation of the
         fees set forth above.


VII.     ALLOCATION OF EXPENSES

The  Subadviser  shall pay the salaries,  employment  benefits and other related
costs of those of its personnel  engaged in providing  investment  advice to the
Portfolio  hereunder,  including,  but not  limited  to,  office  space,  office
equipment, telephone and postage costs.


VIII.    NONEXCLUSIVITY

The  services of the  Subadviser  with  respect to the  Portfolio  are not to be
deemed to be exclusive,  and the Subadviser  shall be free to render  investment
advisory  and  administrative  or other  services  to  others  (including  other
investment companies) and to engage in other activities; provided, however, that
the Subadviser will not undertake to manage a registered investment company with
substantially  similar  objectives,  policies and  restrictions  to those of the
Portfolio  without  obtaining  the  Adviser's  prior  written  approval.  It  is
understood  that officers or directors of the Subadviser are not prohibited from
engaging in any other business activity or from rendering  services to any other
person,  or from  serving as  partners,  officers,  directors or trustees of any
other firm or trust, including other investment advisory companies.

IX.      TERM

This  Agreement  shall  become  effective  at the close of  business on the date
hereof and shall remain in force and effect  through  December 31, 1999,  unless
earlier  terminated  under the provisions of Article X. Following the expiration
of its initial term,  the Agreement  shall  continue in force and effect for one
year  periods,  provided  such  continuance  is  specifically  approved at least
annually:

1.       (a) by the  Board  or  (b) by the  vote  of a  majority  of the
          Portfolio's  outstanding  voting securities (as defined in Section
          2(a)(42) of the 1940 Act), and

2.       by the affirmative vote of a majority of the directors who are
         not parties to this Agreement or interested persons of a party
         to this Agreement  (other than as a director of the Fund),  by
         votes cast in person at a meeting specifically called for such
         purpose.


X.       TERMINATION

This Agreement may be terminated:

         1.      at any time,  without the payment of any  penalty,  by vote of
                 the Board or by vote of a majority of the outstanding voting
                 securities of the Portfolio; or

         2.       by the Adviser,  the Fund, on behalf of the Portfolio,  or the
                  Subadviser  on sixty  (60) days'  written  notice to the other
                  party,  unless  written notice is waived by the party required
                  to be notified; or

         3.       automatically  in the event there is an "assignment"  of 
                  this Agreement,  as defined in the 1940 Act.


XI. LIABILITY

The  Subadviser  shall be liable to the Portfolio and the  Subadviser  and shall
indemnify the Portfolio and the Adviser for any losses incurred by the Portfolio
or the Adviser  whether in the  purchase,  holding,  or sale of any  security or
otherwise,  to the extent that such losses  resulted  from an act or omission on
the part of the  Subadviser  or its officers,  directors or  employees,  that is
found to involve  willful  misfeasance,  bad faith or  negligence,  or  reckless
disregard by the  Subadviser of its duties under this  Agreement,  in connection
with the services rendered by the Subadviser hereunder.

Nothing herein shall relieve the Adviser of its responsibilities to the Fund, as
set forth in the Investment Advisory Agreement.

XII.     NOTICES

Any notices under this Agreement  shall be in writing,  addressed and delivered,
mailed  postage  paid,  or sent  by  other  delivery  service,  or by  facsimile
transmission  to each party at such address as each party may  designate for the
receipt of notice. Until further notice, such address shall be:

         if to the Fund, on behalf of the Portfolio or the Adviser:

   
         242 Trumbull Street  ALT5
         Hartford, Connecticut  06103-1205
         Fax number: 860/275-2158
         Attn:  Secretary
    
         if to the Subadviser:
    
         185 Asylum Street
         Hartford, Connecticut 06103
         Fax number: 860/520-1557
         Attention:  President
     
XIII.    QUESTIONS OF INTERPRETATION

This Agreement  shall be governed by the laws of the State of  Connecticut.  Any
question of  interpretation  of any term or provision of this Agreement having a
counterpart  in or  otherwise  derived  from a term or provision of the 1940 Act
shall be resolved by  reference to such term or provision of the 1940 Act and to
interpretations  thereof, if any, by the United States Courts or, in the absence
of any controlling  decision of any such court, by rules,  regulations or orders
of the Commission issued pursuant to the 1940 Act. In addition, where the effect
of a requirement  of the 1940 Act reflected in any provision of the Agreement is
revised by rule, regulation or order of the Commission,  such provision shall be
deemed to incorporate the effect of such rule, regulation or order.


XIV.     SALES PROMOTION

        The Subadviser may not use any sales  literature,  advertising  material
(including material disseminated through radio, television,  or other electronic
media) or other  communications  concerning Portfolio shares or that include the
name of the  Portfolio or the Adviser  without  obtaining  the  Adviser's  prior
written approval.


IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed
in duplicate by their respective officers on the _____ day of __________, 1998.


                                              Aeltus Investment Management, Inc.

Attest:                                              By
                                                     Name
Name                                                 Title
Title

                                                 Bradley, Foster & Sargent, Inc.

Attest:                                              By
                                                     Name
Name                                                 Title
Title
                                 [NAME OF FUND]
                                  on behalf of
                                              [Name of Value Opportunity Series]

Attest:                                              By
                                                     Name
Name                                                 Title
Title


<PAGE>


                        AETNA SERIES FUND, INC. ("SERIES FUND")
                          Aetna Value Opportunity Fund

                THIS PROXY CARD IS SOLICITED ON BEHALF OF THE BOARD
                         OF DIRECTORS OF THE SERIES FUND


THIS PROXY CARD,  WHEN  PROPERLY  EXECUTED  AND  RETURNED,  WILL BE VOTED IN THE
MANNER DIRECTED HEREIN BY THE  UNDERSIGNED.  IF NO DIRECTION IS MADE, THIS PROXY
CARD WILL BE VOTED FOR APPROVAL OF THE PROPOSAL.

                         Dated: __________________, 1998


        Please sign exactly as name appears on this card. When account is
        joint tenants, all should sign. When signing as administrator, trustee
        or guardian, please give title. If a corporation or partnership,
        sign in entity's name and by authorized persons.



                             X______________________
                             X______________________



Please refer to the Proxy  Statement  for a discussion  of these  matters.  This
proxy  card  is  solicited  in  connection  with  the  special  meeting  of  the
shareholders of Aetna Value  Opportunity  Fund to be held at 9:00 a.m.,  Eastern
Time, on September 4, 1998,  and at any  adjournment  thereof.  THIS PROXY CARD,
WHEN  PROPERLY  EXECUTED,  DIRECTS J. SCOTT FOX AND AMY R.  DOBERMAN TO VOTE THE
SHARES  LISTED ON THE FRONT OF THIS CARD AS DIRECTED AND REVOKES ALL PRIOR PROXY
CARDS.

Please vote by filling in the  appropriate  box below,  as shown,  using blue or
black ink or dark pencil. Do not use red ink.

[   ] [box is filled in solidly]

 1.       Approval of the Subadvisory Agreement.

         [   ] FOR                  [   ] AGAINST             [   ] ABSTAIN

IN THEIR  DISCRETION,  THE  PROXIES  ARE  AUTHORIZED  TO VOTE  UPON  SUCH  OTHER
BUSINESS,  INCLUDING ANY ADJOURNMENT OF THE MEETING, AS MAY PROPERLY COME BEFORE
THE MEETING.



<PAGE>

                       AETNA VARIABLE PORTFOLIOS, INC. ("AVPI")
                           Aetna Value Opportunity VP

                THIS AUTHORIZATION CARD IS SOLICITED ON BEHALF OF THE BOARD
                              OF DIRECTORS OF AVPI


THIS AUTHORIZATION  CARD, WHEN PROPERLY EXECUTED AND RETURNED,  WILL BE VOTED IN
THE MANNER  DIRECTED  HEREIN BY THE  UNDERSIGNED.  IF NO DIRECTION IS MADE, THIS
AUTHORIZATION CARD WILL BE VOTED FOR APPROVAL OF THE PROPOSAL.

                         Dated: __________________, 1998


         Please sign exactly as name appears on this card. When account is
       joint tenants, all should sign. When signing as administrator, trustee
         or guardian, please give title. If a corporation or partnership,
                   sign in entity's name and by authorized persons.



                             X______________________
                             X______________________



Please refer to the Proxy  Statement  for a discussion  of these  matters.  This
authorization  card is solicited in connection  with the special  meeting of the
shareholders  of Aetna  Value  Opportunity  VP to be held at 9:00 a.m.,  Eastern
Time, on September 4, 1998, and at any adjournment  thereof.  THIS AUTHORIZATION
CARD, WHEN PROPERLY  EXECUTED,  DIRECTS J. SCOTT FOX AND AMY R. DOBERMAN TO VOTE
THE SHARES  LISTED ON THE FRONT OF THIS CARD AS  DIRECTED  AND REVOKES ALL PRIOR
AUTHORIZATION CARDS.

Please vote by filling in the  appropriate  box below,  as shown,  using blue or
black ink or dark pencil. Do not use red ink.

[   ] [box is filled in solidly]

 1.       Approval of the Subadvisory Agreement.

         [   ] FOR                  [   ] AGAINST             [   ] ABSTAIN

IN THEIR  DISCRETION,  THE  PROXIES  ARE  AUTHORIZED  TO VOTE  UPON  SUCH  OTHER
BUSINESS,  INCLUDING ANY ADJOURNMENT OF THE MEETING, AS MAY PROPERLY COME BEFORE
THE MEETING.







© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission